UGenDx Limited is a cutting-edge biotechnology company focused on revolutionizing non-invasive diagnostics through liquid biopsy. Our mission is to address the longstanding challenges in the field of urine-based liquid biopsy, with a particular focus on sample preservation and accuracy of diagnosis.
Our innovative urine cell filtration device offers a breakthrough solution for rapid processing and preservation of urine samples, enabling precise and reliable diagnostic results. This advanced technology is designed to detect and monitor various urological conditions, including bladder cancer, endometrial cancer, urinary tract cancer, and prostate cancer.
At UGenDx, we are committed to advancing healthcare by providing accessible, non-invasive diagnostic tools that can improve early detection and treatment outcomes. With a focus on innovation and patient care, we are transforming the future of diagnostics.
Company Details
- Founded
- 2024
- Address
- Newcastle Upon Tyne , Ne128rl, Gb
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://ugendx.co.uk/
- Keywords
- Assay development, Immunocytochemistry, Liquid Biopsy, Urine cytology, Immunocytochemistry, Microfluidics, Urine cell filtration., Immunohistocheistry, Tissue culture, Bladder cancer.
- HQ
- Newcastle upon tyne
Ugendx Limited Questions
Ugendx Limited's website is https://ugendx.co.uk/
Ugendx Limited's LinkedIn profile is https://uk.linkedin.com/company/ugendx
Ugendx Limited's industry is
Biotechnology Research
Ugendx Limited's categories are Biotechnology Research
Ugendx Limited's founding year is 2024
